• 短篇论著 • 上一篇    下一篇

拉莫三嗪单药治疗新诊断小儿癫痫的临床疗效分析

程新旺1,冯占辉2   

  1. 1. 天津市第一中心医院
    2. 贵阳医学院附属第一医院
  • 收稿日期:2012-02-20 修回日期:2012-03-31 出版日期:2012-10-15 发布日期:2012-10-15
  • 通讯作者: 冯占辉

Clinical effects of Lamotrigine monotherapy among children patients with newly diagnosed epilepsy

  • Received:2012-02-20 Revised:2012-03-31 Published:2012-10-15 Online:2012-10-15

摘要: 目的:观察拉莫三嗪对新诊断小儿癫痫的疗效和安全性。方法:选取天津市第一中心医院和贵阳医学院附属医院癫痫门诊或住院80例新诊断小儿癫痫患者,给予拉莫三嗪单药治疗。起始剂量0.5mg/(kg?d),每周增加0.5mg/kg,至第4周加至目标剂量4.0-5.0mg/(kg?d),分两次口服。观察药物的不良反应及药物疗效。结果:80例患者中完全控制31例,显效27例,有效8例,无效14例,总有效率为82.5%。各发作类型中以强直一阵挛发作疗效最佳,总有效率为95.0%,不良反应以皮疹、头痛、嗜睡较为多见,80例患者中有7例出现上述反应,发生率为8.7%。随着继续用药,症状消失。结论:拉莫三嗪应用治疗小儿癫痫总有效率较高,副作用出现率低,是治疗小儿癫痫的一种安全、有效药物。

关键词: 抗癫痫药物, 拉莫三嗪, 单药治疗

Abstract: Objective: To understand the clinical effective of lamotrigine for Children patients with newly diagnosed epilepsy. Methods: 80 cases of children patients with newly diagnosed epilepsy, were treated with lamotrigine. LTG was used originally at a dose of 0.5mg/(kg?d), 4 weeks achieved the goal dosage (4.0-5.0mg/(kg?d)). We observed their changes of seizure frequencies compared with the basic-line before the treatments. Result: There are 31 patients seizure free, 27 patients whose frequencies were reduced by more than 75%, 8 patients’ frequencies were reduced by more than 50%. The total effective reached 82.5%. Patients with GTCS obtained the best effects. The total effective reached 95.0%. Related adverse effcts included asthenia, somnolence, skin rashes. These adverse effects disappeared spontaneously without any special treatment. Conclusion: lamotrigine is a safe effective drug for Children patients with newly diagnosed epilepsy.

Key words: Antiepilepsy drug, lamotrigine(LTG), Monotherapy